"10.1371_journal.pgen.1004256","plos genetics","2014-04-03T00:00:00Z","Ana Osorio; Roger L Milne; Karoline Kuchenbaecker; Tereza Vaclová; Guillermo Pita; Rosario Alonso; Paolo Peterlongo; Ignacio Blanco; Miguel de la Hoya; Mercedes Duran; Orland Díez; Teresa Ramón y Cajal; Irene Konstantopoulou; Cristina Martínez-Bouzas; Raquel Andrés Conejero; Penny Soucy; Lesley McGuffog; Daniel Barrowdale; Andrew Lee; SWE-BRCA; Brita Arver; Johanna Rantala; Niklas Loman; Hans Ehrencrona; Olufunmilayo I Olopade; Mary S Beattie; Susan M Domchek; Katherine Nathanson; Timothy R Rebbeck; Banu K Arun; Beth Y Karlan; Christine Walsh; Jenny Lester; Esther M John; Alice S Whittemore; Mary B Daly; Melissa Southey; John Hopper; Mary B Terry; Saundra S Buys; Ramunas Janavicius; Cecilia M Dorfling; Elizabeth J van Rensburg; Linda Steele; Susan L Neuhausen; Yuan Chun Ding; Thomas v O Hansen; Lars Jønson; Bent Ejlertsen; Anne-Marie Gerdes; Mar Infante; Belén Herráez; Leticia Thais Moreno; Jeffrey N Weitzel; Josef Herzog; Kisa Weeman; Siranoush Manoukian; Bernard Peissel; Daniela Zaffaroni; Giulietta Scuvera; Bernardo Bonanni; Frederique Mariette; Sara Volorio; Alessandra Viel; Liliana Varesco; Laura Papi; Laura Ottini; Maria Grazia Tibiletti; Paolo Radice; Drakoulis Yannoukakos; Judy Garber; Steve Ellis; Debra Frost; Radka Platte; Elena Fineberg; Gareth Evans; Fiona Lalloo; Louise Izatt; Ros Eeles; Julian Adlard; Rosemarie Davidson; Trevor Cole; Diana Eccles; Jackie Cook; Shirley Hodgson; Carole Brewer; Marc Tischkowitz; Fiona Douglas; Mary Porteous; Lucy Side; Lisa Walker; Patrick Morrison; Alan Donaldson; John Kennedy; Claire Foo; Andrew K Godwin; Rita Katharina Schmutzler; Barbara Wappenschmidt; Kerstin Rhiem; Christoph Engel; Alfons Meindl; Nina Ditsch; Norbert Arnold; Hans Jörg Plendl; Dieter Niederacher; Christian Sutter; Shan Wang-Gohrke; Doris Steinemann; Sabine Preisler-Adams; Karin Kast; Raymonda Varon-Mateeva; Andrea Gehrig; Dominique Stoppa-Lyonnet; Olga M Sinilnikova; Sylvie Mazoyer; Francesca Damiola; Bruce Poppe; Kathleen Claes; Marion Piedmonte; Kathy Tucker; Floor Backes; Gustavo Rodríguez; Wendy Brewster; Katie Wakeley; Thomas Rutherford; Trinidad Caldés; Heli Nevanlinna; Kristiina Aittomäki; Matti A Rookus; Theo A M van Os; Lizet van der Kolk; J L de Lange; Hanne E J Meijers-Heijboer; A H van der Hout; Christi J van Asperen; Encarna B Gómez Garcia; Nicoline Hoogerbrugge; J Margriet Collée; Carolien H M van Deurzen; Rob B van der Luijt; Peter Devilee; HEBON; Edith Olah; Conxi Lázaro; Alex Teulé; Mireia Menéndez; Anna Jakubowska; Cezary Cybulski; Jacek Gronwald; Jan Lubinski; Katarzyna Durda; Katarzyna Jaworska-Bieniek; Oskar Th Johannsson; Christine Maugard; Marco Montagna; Silvia Tognazzo; Manuel R Teixeira; Sue Healey; kConFab Investigators; Curtis Olswold; Lucia Guidugli; Noralane Lindor; Susan Slager; Csilla I Szabo; Joseph Vijai; Mark Robson; Noah Kauff; Liying Zhang; Rohini Rau-Murthy; Anneliese Fink-Retter; Christian F Singer; Christine Rappaport; Daphne Geschwantler Kaulich; Georg Pfeiler; Muy-Kheng Tea; Andreas Berger; Catherine M Phelan; Mark H Greene; Phuong L Mai; Flavio Lejbkowicz; Irene Andrulis; Anna Marie Mulligan; Gord Glendon; Amanda Ewart Toland; Anders Bojesen; Inge Sokilde Pedersen; Lone Sunde; Mads Thomassen; Torben A Kruse; Uffe Birk Jensen; Eitan Friedman; Yael Laitman; Shani Paluch Shimon; Jacques Simard; Douglas F Easton; Kenneth Offit; Fergus J Couch; Georgia Chenevix-Trench; Antonis C Antoniou; Javier Benitez","Human Genetics Group, Spanish National Cancer Centre (CNIO), Madrid, Spain; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Genotyping Unit (CeGen), Spanish National Cancer Centre (CNIO), Madrid, Spain; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy; Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain; Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain; Oncogenetics Laboratory, University Hospital Vall dHebron, Vall dHebron Institute of Oncology (VHIO), Vall dHebron Institut de Recerca (VHIR), and Universitat Autonoma de Barcelona, Barcelona, Spain; Oncology Service, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Molecular Diagnostics Laboratory IRRP, National Centre for Scientific Research Demokritos Aghia Paraskevi Attikis, Athens, Greece; Molecular Genetics Laboratory (Department of Biochemistry), Cruces Hospital Barakaldo, Bizkaia, Spain; Medical Oncology Service, Hospital Clínico Lozano Blesa, San Juan Bosco, Zaragoza, Spain; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada; Department of Oncology, Lund University, Lund, Sweden; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology, Lund University Hospital, Lund, Sweden; Department of Clinical Genetics, Lund University Hospital, Lund, Sweden; Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, Illinois, United States of America; Departments of Medicine, Epidemiology, and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America; Abramson Cancer Center and Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America; Abramson Cancer Center and Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America; University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Womens Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America; Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, United States of America; Department of Health Research & Policy, Stanford University School of Medicine, Stanford, California, United States of America; Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, Australia; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, University of Melbourne, Melbourne, Victoria, Australia; Department of Epidemiology, Columbia University, New York, New York, United States of America; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America; Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Department of Molecular and Regenerative Medicine, Vilnius, Lithuania; Department of Genetics, University of Pretoria, Pretoria, South Africa; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, United States of America; Center for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Genetics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Clinical Cancer Genetics, City of Hope, Duarte, California, United States of America; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy; Division of Experimental Oncology 1, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy; Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS AOU San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy; Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy; Department of Molecular Medicine, Sapienza University, Rome, Italy; UO Anatomia Patologica, Ospedale di Circolo-Università dellInsubria, Varese, Italy; Unit of Molecular bases of genetic risk and genetic testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Genetic Medicine, Manchester Academic Health Sciences Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom; South East Thames Regional Genetics Service, Guys Hospital London, United Kingdom; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom; Yorkshire Regional Genetics Service, Leeds, United Kingdom; Ferguson-Smith Centre for Clinical Genetics, Yorkhill Hospitals, Glasgow, United Kingdom; West Midlands Regional Genetics Service, Birmingham Womens Hospital Healthcare NHS Trust, Edgbaston, Birmingham, United Kingdom; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom; Sheffield Clinical Genetics Service, Sheffield Childrens Hospital, Sheffield, United Kingdom; Clinical Genetics Department, St Georges Hospital, University of London, London, United Kingdom; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom; Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrookes Hospital, Cambridge, United Kingdom; Institute of Human Genetics, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom; South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom; North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom; Oxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom; Northern Ireland Regional Genetics Centre, Belfast City Hospital, Belfast, United Kingdom; South West Regional Genetics Service, Bristol, United Kingdom; Academic Unit of Clinical and Molecular Oncology, Trinity College Dublin and St Jamess Hospital, Dublin, Eire; Cheshire & Merseyside Clinical Genetics Service, Liverpool Womens NHS Foundation Trust, Liverpool, United Kingdom; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America; Centre of Familial Breast and Ovarian Cancer and Centre for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany; Department of Gynaecology and Obstetrics, Division of Tumor Genetics, Klinikum rechts der Isar, Technical University Munich, Munich, Germany; Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany; Institute of Human Genetics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany; Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany; Institute of Human Genetics, Department of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany; Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany; Institute of Human Genetics, University of Münster, Münster, Germany; Department of Gynaecology and Obstetrics, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany; Institute of Human Genetics, Campus Virchov Klinikum, Charite Berlin, Berlin, Germany; Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University Würzburg, Würzburg, Germany; Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon – Centre Léon Bérard, Lyon, France; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Center for Medical Genetics, Ghent University, Ghent, Belgium; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, New York, United States of America; Prince of Wales Hospital. Sydney, Australia; Ohio State University, Columbus Cancer Council, Columbus, Ohio, United States of America; Division of Gynecologic Oncology, NorthShore University HealthSystem, Evanston, Illinois, United States of America; Division of Gynecologic Oncology, NorthShore University HealthSystem, Chicago, Illinois, United States of America; For Tufts Medical Center, Boston, Massachusetts, United States of America; Yale University School of Medicine, New Haven, Connecticut, United States of America; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The Netherlands; University of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands; Department of Clinical Genetics, Leiden University Medical Center Leiden, Leiden, The Netherlands; Department of Clinical Genetics and GROW, School for Oncology and Developmental Biology, MUMC, Maastricht, The Netherlands; Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Pathology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands; The Hereditary Breast and Ovarian Cancer Research Group, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary; Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland; Department of Oncology, Landspitali University Hospital and BMC, Faculty of Medicine, University of Iceland, Reykjavik Iceland; Laboratoire de Diagnostic Génétique et Service dOnco-hématologie, Hopitaux Universitaire de Strasbourg, CHRU Nouvel Hôpital Civil, Strasbourg, France; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy; Department of Genetics, Portuguese Oncology Institute, Porto, and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal; Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Australia; Kathleen Cuningham Consortium for Research into Familial Breast Cancer, Peter MacCallum Cancer Center, Melbourne, Australia; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America; Center for Individualized Medicine, Mayo Clinic, Scottsdale, Arizona, United States of America; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America; Center for Translational Cancer Research, Department of Biological Sciences, University of Delaware, Newark, Delaware, United States of America; Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Diagnostic Molecular Genetics Laboratory, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, United States of America; Clalit National Israeli Cancer Control Center, Haifa, Israel; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada, and Cancer Care Ontario, Departments of Molecular Genetics and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada; Ontario Cancer Genetics Network: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Human Cancer Genetics, Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America; Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark; Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark; Sheba Medical Center, Tel Aviv, Israel; Canada Research Chair in Oncogenetics, Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Canada","Conceived and designed the experiments: AO RLM GPi JB. Performed the experiments: AO TV RA BH LTM JS KO FJC. Analyzed the data: RLM KKu ACA. Contributed reagents/materials/analysis tools: AO RLM KKu TV GPi RA PP IB MdlH MD OD TRyC IK CMB RAC PS LM DB AL BA JR NLo HE OIO MSB SMD KN TRR BKA BYK CW JLe EMJ ASW MBD MS JHo MBT SSB RJ CMD EJvR LSt SLN YCD TOvH LJ BE AMG MI BH LTM JNW JHe KWe SMan BPe DZ GS BB FM SV AV LV LP LO MGT PR DY JGa SE DF RP EFi GE FLa LI RE JA RD TCo DE JC SHo CB MTi FDo MPo LSi LW PM AD JK CF AKG RKS BW KR CE AM ND NA HJP DN CS SWG DS SPA KKa RVM AG DSL OMS SMaz FDa BPo KC MPi KT FB GR WB KWa TR TCa HN KA MAR TAMvO LvdK JLdL HEJMH AHvdH CJvA EBBG NH JMC CHMvD RBvdL PD EO CL AT MMe AJ CC JGr JLu KD KJB OTJ CM MMo ST MRT SHe CO LG NLi SS CIS JV MR NK LZ RRM AFR CFS CR DGK GPf MKT ABe CMP MHG PLM FLe IA AMM GG AET ABo ISP LSu MTh TAK UBJ EFr YL SPS JS DFE KO FJC GCT ACA JB. Wrote the paper: AO RLM KKu ACA JB.","The authors have declared that no competing interests exist.","2014","04","Ana Osorio","AO",200,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
